JAMA Surgery : Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS

JAMA Network - Ein Podcast von The JAMA Network

Podimo 45 Tage kostenlos testen

Ein Universum voller exklusiver Podcasts und Hörbücher. Klicken Sie hier um loszulegen!

Werbung

Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ

Visit the podcast's native language site